Acupuncture for Shortness of Breath in Cancer Patients

Breast Neoplasms Clinical Trial

Official title:

Acupuncture for Shortness of Breath in Cancer Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00067691
• Other study ID #: R21AT001029-01
• Status: Completed
• Phase: N/A
• First received: August 25, 2003
• Last updated: August 16, 2006
• Start date: November 2001
• Est. completion date: November 2003

Study information

• Verified date: August 2006
• Source: National Center for Complementary and Integrative Health (NCCIH)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether acupuncture is effective in relieving shortness of breath among breast and lung cancer patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: November 2003
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of local or metastatic breast or lung cancer

• Shortness of breath with onset after cancer diagnosis

• Life expectancy of at least 4 weeks

Exclusion Criteria:

• Prior acupuncture

• Other conditions suspected of causing shortness of breath, such as congestive heart failure, sarcoid disease, pneumonia, or obesity

• No chest wall deformity

• Neuromuscular disorders

• Pulmonary vascular disease

• Anemia

• Uncontrolled pain or infection

• Heart valve dysfunction

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Breast Neoplasms
• Dyspnea
• Lung Neoplasms
• Neoplasms

Intervention

Procedure:
• Acupuncture

Locations

Country	Name	City	State
United States	Memorial Sloan-Kettering Institute for Cancer Research	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
National Center for Complementary and Integrative Health (NCCIH)	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States,